Severe cutaneous adverse drug reaction to leflunomide: A report of two cases

Cutaneous and Ocular Toxicology

Volumn 27, Issue 1, 2008, Pages 5-9

  Jian, Xingdong ^a   Guo, Guangran ^a   Ruan, Yanjun ^a   Lin, Dawei ^a   Li, Xingfu ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cutaneous reactions; Leflunomide; Primary Sjogren's syndrome; Systemic lupus erythematosus

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; LEFLUNOMIDE; METHYLPREDNISOLONE; PARACETAMOL; PREDNISONE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; SJOEGREN SYNDROME; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BLISTER; DRUG ERUPTIONS; EXANTHEMA; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; ISOXAZOLES; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; MIDDLE AGED; PULSE THERAPY, DRUG; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 40549125302     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520701662866     Document Type: Article

References (26)

1. Sevilla-Mantilla C, Ortega L, Agúndez JA, Fernández- Gutiérrez B, Ladero JM, Díaz-Rubio M. Leflunomide-induced acute hepatitis. Dig Liver Dis 2004; 36:82-84.
2. Auer J, Hinterreiter M, Allinger S, Kirchgatterer A, Knoflach P. Severe pancytopenia after leflunomide in rheumatoid arthritis. Acta Med Austriaca 2000; 27:131-132.
3. Kamata Y, Nara H, Kamimura T, Haneda K, Iwamoto M, Masuyama J, Okazaki H, Minota S. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 2004; 43:1201-1204.
4. Savage RL, Highton J, Boyd IW, Chapman P. Pneumonitis associated with leflunomide: A profile of New Zealand and Australian reports. Intern Med J 2006; 36:162-169.
5. Hirabayashi Y, Shimizu H, Kobayashi N, Kudo K. Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis. Intern Med 2006; 45:689-691.
6. Bruyn GA, Jansen TL, Ten Brinke A, De Vries M, Houtman PM, van Roon EN. Cavitating pneumonia, a severe complication of leflunomide therapy in chronic polyarthritis. Rheumatology (Oxford) 2007; 46:553-554.
7. Ochi S, Harigai M, Mizoguchi F, Iwai H, Hagiyama H, Oka T, Miyasaka N. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: Autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage. Mod Rheumatol 2006; 16:316-320.
8. Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum 2006; 54:1435-1439.
9. Richards BL, Spies J, McGill N, Richards GW, Vaile J, Bleasel JF, Youssef PP. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Intern Med J 2007; 37:101-107.
10. Gabelle A, Antoine JC, Hillaire-Buys D, Coudeyre E, Camu W. Leflunomide-related severe axonal neuropathy. Rev Neurol (Paris) 2005; 161:1106-1109.
11. Kho LK, Kermode AG. Leflunomide-induced peripheral neuropathy. J Clin Neurosci 2007; 14:179-181.
12. Holm EA, Balslev E, Jemec GB. Vasculitis occurring during leflunomide therapy. Dermatology 2001; 203:258-259.
13. Braun MG, Van Rhee R, Becker-Capeller D. Development and/or increase of rheumatoid nodules in RA patients following leflunomide therapy. Z Rheumatol 2004; 63:84-87.
14. Rozin A, Yigla M, Guralnik L, Keidar Z, Vlodavsky E, Rozenbaum M, Nahir AM, Balbir-Gurman A. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy. Clin Rheumatol 2006; 25:384-388.
15. Coblyn JS, Shadick N, Helfgott S. Leflunomide-associated weight loss in rheumatoid arthritis. Arthritis Rheum 2001; 44:1048-1051.
16. Laborde F, Loeuille D, Chary-Valckenaere I. Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis. Arthritis Rheum 2004;50:3398.
17. Canonne-Courivaud D, Carpentier O, Dejobert Y, Hachulla E, Delaporte E. Lichenoid drug reaction to leflunomide. Ann Dermatol Venereol 2003; 130:435-437.
18. Rivarola de Gutierrez E, Abaca H. Photodistributed lichenoid drug eruption with rhabdomyolysis occurring during leflunomide therapy. Dermatology 2004; 208:232-233.
19. Teraki Y, Hitomi K, Sato Y, Hamamatsu Y, Izaki S. Leflunomide-induced toxic epidermal necrolysis. Int J Dermatol 2006; 45:1370-1371.
20. Shastri V, Betkerur J, Kushalappa PA, Savita TG, Parthasarathi G. Severe cutaneous adverse drug reaction to leflunomide: A report of five cases. Indian J Dermatol Venereol Leprol 2006; 72:286-289.
21. Jakob A, Porstmann R, Rompel R. Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis. J Dtsch Dermatol Ges 2006; 4:324-327.
22. McCoy CM. Leflunomide-associated skin ulceration. Ann Pharmacother 2002; 36:1009-1011.
23. Maddison P, Kiely P, Kirkham B, Lawson T, Moots R, Proudfoot D, Reece R, Scott D, Sword R, Taggart A, Thwaites C, Williams E. Leflunomide in rheumatoid arthritis: Recommendations through a process of consensus. Rheumatology (Oxford) 2005;44:280-286.
24. Emery P. Leflunomide: A new DMARD for rheumatoid arthritis. Hosp Med 2000;61:344-347.
25. Prakash A, Jarvis B. Leflunomide: A review of its use in active rheumatoid arthritis. Drugs 1999; 58:1137-1164.
26. Canonne-Courivaud D, Carpentier O, Dejobert Y, Hachulla E, Delaporte E. Lichenoid drug reaction to leflunomide. Ann Dermatol Venereol 2003; 130:435-437.